National Community Anti-Drug Coalition Institute (NCI)
ID: 357447Type: Forecasted
Overview

Buyer

Office of National Drug Control Policy (ONDCP)

Award Range

$0 - $3M

Eligible Applicants

Nonprofits Without 501(c)(3) Status

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/357447
Timeline
    Description

    The Office of National Drug Control Policy (ONDCP) is forecasting a grant opportunity titled the National Community Anti-Drug Coalition Institute (NCI), aimed at enhancing the capacity of community coalitions to implement evidence-based substance use prevention interventions. The primary objectives of this grant are to increase the effectiveness of community coalitions across the United States and to strengthen the technical assistance and training provided to these coalitions, particularly during the critical adolescent years when substance use initiation is most prevalent. With an estimated total program funding of $2.5 million and a single award anticipated, eligible applicants include national nonprofit organizations with expertise in community anti-drug coalitions. Interested parties should note that the estimated synopsis post date is December 9, 2024, with a closing date for applications on February 7, 2025, and the expected award date is March 10, 2025. For further inquiries, applicants can contact Helen Hernandez, Assistant Director for Drug Free Communities, at Helen_Hernandez@ondcp.eop.gov or by phone at 202-395-6665.

    Point(s) of Contact
    Helen Hernandez Assistant Director for Drug Free Communities
    (202) 395-6665
    Helen_Hernandez@ondcp.eop.gov
    Files
    No associated files provided.
    Similar Opportunities
    Drug-Free Communities (DFC) Support Program – NEW (Year 1)
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC) is inviting applications for the Drug-Free Communities (DFC) Support Program grants for Fiscal Year 2026, aimed at preventing youth substance use. This program seeks to establish and strengthen collaborations among community coalitions, public and private non-profit agencies, and government entities to reduce substance abuse among youth and, over time, among adults by addressing community risk factors. The DFC Support Program is critical for fostering safe and healthy communities, with an estimated total funding of $31,250,000 available for approximately 50 awards, each ranging from $0 to $125,000. Interested applicants, particularly community-based coalitions that have not previously received a DFC grant, must submit their applications electronically by April 14, 2026, with awards expected to be announced by August 31, 2026. For further inquiries, applicants can contact Christi Jones at DFCNOFO@cdc.gov.
    Comprehensive Addiction and Recovery Act (CARA)
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC) is offering grants under the Comprehensive Addiction and Recovery Act (CARA) to support community-based coalitions addressing the crises of opioid, methamphetamine, and prescription drug misuse among youth aged 12-18. Eligible applicants include nonprofit organizations, state and local governments, and other entities that have documented higher-than-average rates of substance misuse, specifically those that are current or former recipients of the Drug-Free Communities (DFC) Support Program. This initiative aims to enhance coalition activities to prevent and reduce substance use among American youth, with a total estimated funding of $16,875,000 available for approximately 45 awards, each ranging from $0 to $75,000. Interested parties should submit their applications electronically by March 16, 2026, and can direct inquiries to Christi Jones at CARANOFO@cdc.gov.
    Notice of Intent to Publish a Funding Opportunity for NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity titled "NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity," which aims to support research initiatives that address the intersection of substance use and racial equity. This grant program, utilizing the DP1 activity code, is designed to foster meaningful collaborations and innovative projects in this critical area of health research. With an estimated total program funding of $3.5 million and an award ceiling of $700,000, the anticipated application period will open in Fall 2025, following the expected publication of the notice of funding opportunity in Spring 2025. Interested applicants should prepare to submit their proposals by the estimated closing date of October 14, 2025, with awards expected to be made by July 1, 2026.
    Drug-Free Communities (DFC) Support Program – COMPETING CONTINUATION (Year 6)
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC) is inviting applications for the Drug-Free Communities (DFC) Support Program – Competing Continuation (Year 6) grant, aimed at supporting community-based coalitions in their efforts to prevent and reduce youth substance use. Eligible applicants include organizations that have previously received DFC funding and are either resuming after a lapse or applying for a second five-year funding cycle, with a focus on collaboration among various community sectors to promote a drug-free environment. This grant opportunity, with an estimated total funding of $31.25 million and an award ceiling of $125,000, is critical for addressing substance use issues among youth and will accept applications until April 14, 2026. Interested parties can reach out to Christi Jones at DFCNOFO@cdc.gov for further information.
    Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support
    National Institutes of Health
    The National Institutes of Health (NIH) is seeking to establish a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through a Cooperative Agreement aimed at enhancing the development of new pharmacotherapeutics for SUD. The Center will focus on educating researchers in formal product development and providing technical and financial support for initial experiments, with an emphasis on creating a product development curriculum and fostering collaborations within the research community. This initiative is crucial for advancing drug addiction research and supporting the translation of innovative concepts into practical applications. The estimated total program funding is $3 million, with one award expected, and interested parties can contact Dr. Tam Nguyen at Tam.Nguyen@nih.gov or (301) 451-1203 for further information. The estimated synopsis post date is November 21, 2025, with applications expected to close on January 27, 2026, and the project anticipated to start on September 1, 2026.
    NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) to support institutional research career development programs aimed at clinician scientists. This grant is designed to provide intensive supervised research training and career development experiences, ultimately leading to research independence in the field of substance use and substance use disorders. The program encourages applications focusing on various scientific areas, including neuroimaging, genetics, medication development, and implementation science, among others. Interested applicants from private institutions of higher education should prepare for the upcoming Notice of Funding Opportunity (NOFO), with an estimated synopsis post date of July 3, 2025, and a close date of August 5, 2025. For further inquiries, applicants can contact Lindsey Friend, Ph.D., at NIDA via email at NIDATraining@nida.nih.gov or by phone at 301-402-1428.
    Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at accelerating substance use research through the utilization of existing data, specifically under the R21 grant mechanism. This initiative seeks to foster innovative research projects that leverage pre-existing datasets to enhance understanding and treatment of substance use disorders. The total estimated funding for this program is $2 million, with an award ceiling of $200,000 per project and an anticipated three awards to be made. Interested applicants should note that the NOFO is expected to be published in Fall 2024, with applications due in Spring 2025, and the estimated award date is set for April 1, 2026.
    Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity announcement for research aimed at accelerating the pace of substance use research using existing data, specifically under the R01 grant mechanism. This initiative seeks to promote innovative research projects that leverage existing datasets to enhance understanding and treatment of substance use disorders, with the goal of fostering meaningful collaborations among researchers. The estimated total program funding is $2 million, with approximately three awards expected to be made, and the anticipated application due date is in Spring 2025, following the publication of the Notice of Funding Opportunity in Fall 2024. For further details, potential applicants should prepare to submit their proposals by the estimated close date of June 17, 2025, with awards expected to be announced by April 1, 2026.
    Neural Ensembles & Used Substances (NExUS) Collaboratory : Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Neural Ensembles & Used Substances (NExUS) Collaboratory," aimed at building a multimodal inventory of cell ensembles that encode the effects of addictive substances. This initiative seeks to advance the understanding of neural cell populations and their alterations due to substance-related experiences, with specific goals including the collection of granular datasets, integration of various data modalities, and the development of analytical tools for ensemble activity. The grant, which has a funding ceiling of $700,000 and anticipates awarding four grants, is open to a diverse range of applicants, including tribal governments, federal agencies, and non-domestic entities. Interested parties can reach out to Olivier Berton at olivier.berton@nih.gov or by phone at 301-827-7771 for further information, with applications expected to be submitted by June 2, 2026, and project start dates anticipated for April 1, 2027.
    Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to release a Notice of Funding Opportunity (NOFO) aimed at supporting research for the development of medications to prevent and treat substance use disorders (SUDs) and overdose. This initiative will focus on preclinical and clinical research studies that can rapidly advance candidate interventions toward regulatory approval or clinical adoption, encouraging collaborative efforts among experts in various fields such as pharmacology, toxicology, and clinical trials. While applications are not currently being solicited, interested small businesses are encouraged to begin forming partnerships and developing projects in anticipation of the opportunity, with an estimated synopsis post date of August 15, 2025, and a projected award date of July 1, 2026. For further inquiries, potential applicants can contact Drew Townsend, Ph.D., at drew.townsend@nih.gov or by phone at 301-443-4577.